Precision and Performance: The Power of Biostatistics

How biostatistical expertise drives efficiency, integrity, and regulatory compliance in clinical research.

Biostatistics and biostatistical analysis are foundational elements of all evidence-based clinical research. For MedTech sponsors, designing your trial to incorporate these practices from the start of your project will allow for valuable insights and quantifiable analytics that enable efficiency and accuracy through all stages of your study. Clinical Research Organizations (CROs) understand that the role and application of biostatistics is critical — and is particularly important in quality trial design as it helps sponsors maintain integrity of all clinical trial results. This can be especially true when it comes to IVD clinical trials, where large sample sizes, instrument data collection, and intricate comparison types often create complex data.

In our experience as a global CRO, here are five key ways in which the utilization of biostatistics can ensure robust, valid, and credible clinical trial results:

1. Rigorous Clinical Trial Design Development

Many facets of trial design require statistical input, and the creation of a Statistical Analysis Plan can help guide well-informed decision-making while drafting a clinical trial protocol. Biostatistics is a key tool in:

• Determining the most appropriate trial design for the device being evaluated and mapping how the data will be analyzed.
• Avoiding bias using randomization and blinding.
• Sample size determination and justification.
• Endpoint determination and criteria for termination.
• Specification of efficacy parameters.
• Incorporating Real-World Evidence (RWE) to validate performance in broader populations.

Regulatory agencies increasingly emphasize adaptive trial designs when it might be advantageous (e.g., adoption for appropriate subgroup representation, blind sample size reassessment) and the integration of RWE. Biostatistics enables the flexibility to adjust trial parameters while maintaining scientific rigor.

2. Timely, Accurate, and Actionable Clinical Trial Monitoring

Incorporating biostatistical evaluations of your data during trial execution helps monitor performance and can inform decision-making through:

• Detection of anomalies that may indicate data quality issues.
• Statistical review of the data at the end prior to database lock.

The rise of decentralized clinical trials (DCTs) presents unique challenges for trial monitoring. Biostatisticians now manage diverse data streams from remote monitoring devices and ensure statistical validity across heterogeneous trial setups.

3. Comprehensive Data Analysis

At trial conclusion, biostatistics plays a vital role in analyzing data to ensure robust, reproducible results. This involves:

• Accounting for missing, unused, or spurious data including outliers.
• Identifying trends both broadly and within subgroups.
• Calculating sensitivity, specificity, corresponding confidence intervals, and other clinical performance indicators.

Advanced data visualization (ADV), Artificial Intelligence (AI), and Machine Learning (ML) tools are increasingly being integrated into biostatistical workflows, allowing richer insights and more efficient trend analysis. These ADV/AI/ML-powered approaches enable interactive review of multiple data points at one time, the identification of complex, non-linear patterns in data, providing a deeper understanding of device performance and potential areas for optimization.

4. Impactful Reporting

Biostatistics helps sponsors present data in a way that highlights safety, efficacy, and clinical utility of your device. A well-structured clinical (statistical) report enhances the credibility of trial outcomes and accelerates regulatory approval. Key contributions of impactful reporting include:

• Crafting clear and compelling narratives that demonstrate the device’s performance and clinical relevance.
• Providing key figures and visualizations that support your device is safe to use and has clinical utility.
• Enhancing the credibility and acceptance of your results by demonstrating that they are valid, relevant, and representative.

5. Ensuring Compliance with Regulatory Standard

Regulatory bodies like the FDA value the robust application of biostatistics in clinical trial design and reporting, particularly as they address emerging technologies like AI-enabled diagnostics and laboratory-developed tests (LDTs). Biostatistics ensures:

• Adherence to Good Clinical Practice (GCP) standards.
• Proper application of statistical principles so all data is structured, captured, and documented to provide high-quality and accurate results.
• Compliance with best practices and new regulatory guidelines, such as FDA initiatives for AI and LDTs.

How Beaufort Can Help

Biostatistics is vital for making evidence-based decisions about the safety, efficacy, and overall value of your MedTech product. Beaufort CRO’s team of biostatisticians turns your data into powerful insights. We leverage a deep understanding of regulatory agency requirements and apply sound statistical principles to provide robust and rigorous analyses and reporting. Our knowledge and skill in bridging data collection and statistical analysis enable us to provide the supporting evidence necessary for a successful regulatory submission.

Regardless of where you are in the planning and execution of your MedTech trial, our team can provide scalable solutions to meet the exact biostatistical needs of your project. Beaufort’s CRO solutions include strategic consulting, statistics, and statistical programming as a standalone service or bundled with comprehensive clinical research, regulatory consulting, and data management.

Contact us to learn more our biostatistical expertise and full suite of CRO solutions can support your next MedTech project.

The clinical research landscape for in-vitro diagnostics (IVD) and medical devices is experiencing a rapid evolution driven by technological advancements.  The COVID-19 pandemic certainly spurred the development and integration of new technology platforms with necessity largely driving industry adoption. However, in the wake of the pandemic, many sponsors are not realizing the full potential of the latest advances to improve the management and execution of their clinical research programs.

As a forward-thinking Contract Research Organization (CRO), Beaufort has maintained momentum and continues to apply best-of-breed technology solutions that deliver measurable benefits for sponsors, sites, and patients. This technology focus has allowed our clients the ability to leverage our expertise and apply these innovations to streamline processes, enhance data quality, ensure regulatory compliance, and, ultimately, simplify and accelerate the development of ground-breaking products.

Optimizing the IVD and Medical Device Trial Journey with Technology

There are a wide variety of systems and tools that can help optimize operations within the clinical research paradigm and offer time and cost savings for sponsors.

• eSource and Direct Data Capture:

  Data acquisition within the trial environment remains a significant challenge.  Studies are capturing more and more data all while maintaining the mandate for safety, quality, and completeness.  For diagnostic trials, eSource allows for the direct capture of data from laboratory instruments and laboratory information management systems (LIMS), eliminating manual transcription errors and ensuring data integrity. Similarly, for medical device trials, eSource can integrate with device data streams, providing real-time insights into device performance.  Direct Data Capture (DDC) allows clinical sites to input information directly in the Electronic Data Capture (EDC) system, removing cumbersome and time-intensive transcription from paper.

• eConsent and Patient Engagement:

  Providing the ability to engage patients wherever they might be, eConsent platforms deliver a user-friendly interface for patients to electronically review informed consent documents, ask questions, and provide electronic signatures, enhancing patient engagement and streamlining the consent process. In addition, eConsent platforms can integrate directly with the EDC, allowing for efficiencies like automatic subject creation and the triggering of consent-driven workflows. Integration of hybrid solutions that continue to offer paper-based options helps eliminate adoption concerns for subject populations that are hesitant to use electronic forms. 

• Data Integration and Real-Time Visibility:

  Fragmentation of data across disparate systems can hinder efficient trial management. Advanced data integration tools allow for seamless exchange of information between clinical trial management systems (CTMS), LIMS, EDC and device data streams, providing a holistic view of the trial in real-time.  Beaufort has found that having integrated platforms allows for the rapid performance of interim data analysis  and enhanced visibility into overall trial trends and potential issues.

• Operational Analytics and Data-Driven Decisions:

  Operational performance is crucial to running a successful trial.  By bringing together data from various clinical platforms, the savvy CRO is able to provide key performance indicators around monitoring and site performance. These insights enable proactive course correction, improved resource allocation, and optimized trial execution.

• Cybersecurity and Data Protection:

  The backdrop of ever-evolving cybersecurity threats presents sponsors with considerable challenges in ensuring their products are both compliant and secure.  Add to this increasing regulatory requirements and it becomes critical to select a partner with extensive cybersecurity experience.  Maintaining compliance with industry regulations like 21 CFR Part 11, HIPAA and GDPR is paramount.  In addition, recent regulatory guidance has greatly expanded the need to document all components of a proposed product to include vulnerability assessment and threat modeling.

• Automation and Streamlined Workflows:

  Repetitive tasks such managing regulatory documents, scheduling site visits and monitoring trial timelines can be automated, freeing up valuable human resources for higher-level activities like data analysis, risk management, recruitment/enrollment, and protocol development.

The Power of Partnership: Why Technical Experience Matters

Applying a holistic and platform-agnostic view ensures access to the best-fit solutions for each specific IVD or medical device trial

A CRO’s established relationships with a wide variety of platform providers offer a significant advantage for sponsor programs. Applying a holistic and platform-agnostic view ensures access to the best-fit solutions for each specific IVD or medical device trial, considering factors such as device compatibility, regulatory compliance, and integration capabilities.

Beaufort’s team has considerable experience in evaluating and utilizing the latest technology solutions. We bring a deep understanding of the strengths and value of leading platforms and can provide seamless integration and ongoing support, maximizing efficiencies and minimizing disruption for study teams.

Navigating the Evolving Regulatory Landscape and Addressing Emerging Challenges

The regulatory landscape for IVD and medical devices has also been evolving to address guidance issues as it relates to cybersecurity and technology. It is critical for a CRO to proactively monitor regulatory changes and ensure their technology stack remains compliant with the latest guidelines, such as the EU IVDR and the US FDA’s regulations for medical devices. Additionally, rapidly advancing fields like Artificial Intelligence (AI) hold exciting potential in areas like image analysis and clinical trial design, but also raise questions about validation, ethical considerations, and regulatory clarity. A proactive CRO, like Beaufort, actively engages with regulatory bodies and industry stakeholders to address these challenges and ensure trials remain compliant and ethically sound.

Choosing the Right Partner for Success

Selecting the right CRO is crucial for the success of IVD and medical device trials. Look for a partner with:

• Proven track record of leveraging technology:

  Experience in applying the latest technological advancements specifically within the context of IVD and medical device trials.

• Established relationships with leading platform providers:

  Access to a wide range of best-fit technology solutions tailored to the specific needs of your trial.

• Commitment to navigating the evolving regulatory landscape:

  Proactive approach to ensuring compliance with the latest IVD and medical device regulations.

• Deep understanding of IVD and medical device workflows:

  Expertise in streamlining trial processes and optimizing data collection specific to these fields.

• Thorough knowledge of evolving Cybersecurity and Privacy requirements:

  Wide experience with documenting and performing cybersecurity risk assessments, threat modeling, vulnerability remediation, and change management.

By partnering with a tech-savvy CRO like Beaufort that demonstrates these qualities, you gain a valuable extension of your team, equipped to drive efficiency, data quality, and ultimately, accelerate the development of innovative IVD and medical device solutions that improve patient care.

Contact us today to see how Beaufort applies technology to support your next clinical research project.

Learn More